Udayavni Special

Dr Reddy’s launches Hervycta to treat cancer in India


Team Udayavani, Jul 26, 2018, 12:00 PM IST

New Delhi: Drug major Dr Reddy’s Laboratories (DRL) today announced the launch of Hervycta, indicated for the treatment of certain types of cancer, in India.

Hervycta (Trastuzumab), a biosimilar of Roche’s Herceptin in India, is used for treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer).

Hervycta is available in strengths of 150 mg and 440 mg multiple dose vials, the company said in a regulatory filing.

“We strive every day to do what matters most for patients. Hervycta is a step forward in our effort to accelerate access to cancer patients in India, in the Oncology biosimilar space,” Dr Reddy’s Laboratories CEO-Branded Markets (India and Emerging Markets) MV Ramana said.

Quoting Ipsos data, the company said the Herceptin and its biosimilars had India sales of Rs 290 crore for the most recent 12 months ending in December 2017.

Dr Reddy’s currently has four biosimilar products commercialised in India and various emerging markets, and an active pipeline of several biosimilar products in the oncology and immunology space.

DRL shares were trading 1.01 per cent up at Rs 2,110 apiece on the BSE. 

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

100 crore vaccine doses answers all concerns raised on India: PM Modi

Mysuru double murder: Son brutally kills father, his lover

Six great India-Pakistan clashes in white-ball cricket

Was offered Rs 300-crore bribe to clear deals of ‘Ambani’, ‘RSS-linked man’: Ex-J&K Guv

All regional languages kept in minor subjects category for 1st term exams for class 10, 12: CBSE

Karnataka Bypolls: ‘Mind your language’ says EC to rival political parties

Overpasses for Santhekatte and Ambalpady junctions approved: Minister Shobha Karandlaje

Related Articles More

62.2% death row prisoners diagnosed with at least one mental illness: Study

Six popular beliefs about colds: experts explain the facts

Viral infections may promote Alzheimer’s like diseases: Study

COVID: new antibody treatment could offer up to 18 months’ protection against severe disease

COVID-19 and pregnancy: Women regret not getting the vaccine

MUST WATCH

The invitation of folk-style song

News Bulletin 21-10-2021

HOW TO GROW FOREIGN HYBRID PLANTS

Heavy Rain At Srirangapattana

Viral Video : Leopard Attack at Chikkamagaluru


Latest Additions

100 crore vaccine doses answers all concerns raised on India: PM Modi

Mysuru double murder: Son brutally kills father, his lover

Bunge India seeks to clear ‘unhealthy’ tag from vanaspati

Bunge India seeks to clear ‘unhealthy’ tag from vanaspati

Six great India-Pakistan clashes in white-ball cricket

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.